Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: Use of Copeptin in Diabetes Insipidus

View source ↗

Summary

A clinical trial investigating copeptin in diabetes insipidus has completed, with primary polydipsia included as a condition studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Diabetes Insipidus, Primary Polydipsia | Status: COMPLETED